Medical cannabis for the reduction of opioid dosage in the treatment of non-cancer chronic pain: a systematic review.

ABSTRACT:

Background

Medical cannabis (MC) is currently being used as an adjunct to opiates given its analgesic effects and potential to reduce opiate addiction. This review assessed if MC used in combination with opioids to treat non-cancer chronic pain would reduce opioid dosage.

Methods

Four databases-Ovid (Medline), Psyc-INFO, PubMed, Web of Science, and grey literature-were searched to identify original research that assessed the effects of MC on non-cancer chronic pain in humans. Study eligibility included randomized controlled trials, controlled before-and-after studies, cohort studies, cross-sectional studies, and case reports. All databases were searched for articles published from inception to October 31, 2019. Cochrane's ROBINS-I tool and the AXIS tool were used for risk of

SUBMITTER: Okusanya BO 

PROVIDER: S-EPMC7388229 | biostudies-literature | 2020 Jul

REPOSITORIES: biostudies-literature